Objective: To investigate the effect of Olibrat fat emulsion on medium-term food intake and appetite in non-obese subjects. Design: Double-blind, placebo-controlled, within-subject crossover. Setting: University of Ulster, Coleraine. Subjects: A total of 28 subjects (14 male, 14 female). Interventions: Subjects were randomly assigned to receive either a 200 g portion of test (5 g of Olibrat fat) or control (5 g milk fat) yoghurt for breakfast for 2 Â 3 week 'study' phases, separated by a 3-week 'wash-out' phase. On days 1, 8 and 22 of the study phases, food intake 4 h post-consumption of the yoghurt was assessed by pre-and post-covert weighing at an ad libitum buffet-style test lunch. Throughout each of these study days, appetite was assessed using visual analogue scales (VAS) at regular intervals. For the remainder of the study days, and the following 24 h ('post-study days'), subjects reported their food intake using weighed dietary records. Results: Consumption of the Olibrat emulsion had no significant effect on mean energy, macronutrient or amounts of food consumed at the lunch 4 h post-consumption. Self-reported food intakes indicated that there was no significant effect of the emulsion on energy intakes for the remainder of each study day and post-study days. There was considerable individual variation in food intakes following consumption of the Olibrat emulsion, with 46, 59 and 57% of subjects reducing their energy intakes at lunch on days 1, 8 and 22. There was no consistent effect of the emulsion on appetite ratings. Conclusions: In contrast to earlier studies, there was no evidence of a short-or medium-term effect of the Olibrat emulsion on food intake or appetite. This could be owing to numerous confounding factors influencing eating behaviour and/or the different study design used in the present study.
Introduction
It is generally accepted that food intake in free-living humans is largely controlled by appetite. If this is the case, it is logical to assume that the satiating power of food will play an important role in the regulation of eating behaviour (Blundell and Tremblay, 1995) . In terms of food components, macronutrients are thought to exert independent effects on satiety, and although subject to controversy, protein is generally regarded as the most satiating macronutrient and fat as the least satiating (Cotton et al., 1994; Blundell and MacDiarmid, 1997; Poppitt et al., 1998) . However, the effect of dietary fat on satiety and food intake may vary depending on physicochemical properties of the constituent fatty acids (French, 1999 (French, , 2004 . For example, medium-chain triglycerides may be more satiating than long-chain triglycerides, and therefore may be capable of limiting the consumption of excess energy associated with high-fat diets (Rolls et al., 1988; Stubbs and Harbron, 1996; Van Wymelbeke et al., 1998) . It is also possible that polyunsaturated fatty acids elicit more potent satiating properties compared to monounsaturated fatty acids and saturated fatty acids (Lawton et al., 2000) .
If the macronutrient of foods could be manipulated to increase their satiating properties, thereby assisting in attenuating positive energy balance, they could conceivably play a role in effective weight management strategies. Olibrat, a fat emulsion formulated from palm oil and oat oil fractions, is an example of a functional food ingredient that aims to reduce food intake by promoting and maintaining satiety. Although the exact mechanism is unclear, it is thought that the satiating power of the Olibrat emulsion is owing to the physio-chemical stability of the emulsion, rather than the constituent of the emulsion per se. Undigested fat can delay or prolong the transit of food through the intestine in order to maximise digestion, a phenomenon referred to as the jejunal brake in the proximal intestines and the ileal brake in the distal intestines. It has been speculated that the Olibrat emulsion may elicit its satiating power via the ileal brake, possibly by prolonging or altering the release or effect of peptides associated with the ileal brake. Previous studies demonstrated that consumption of yoghurt containing the Olibrat fat emulsion significantly decreased energy intakes in lean, overweight and obese subjects for up to 8 h post-consumption relative to yoghurt containing milk fat only (Burns et al., 2000 (Burns et al., , 2001 . Moreover, self-reported energy intakes of the subjects showed that food intake remained suppressed for a further 24 h (Burns et al., 2001 (Burns et al., , 2002 .
Although these results appear promising, they provide no insight as to whether this suppression of food intake would persist in the longer-term. Energy compensation or habituation to the emulsion leading to lack of responsiveness are two possible outcomes that may result from longer-term consumption of the emulsion. In addition, the initial studies demonstrated that not all subjects reduced their food intake in response to the Olibrat emulsion. Consequently, the aim of the present study is to investigate the effect of Olibrat fat emulsion on medium-term (up to 3 weeks) food intake and appetite response in free-living non-obese subjects.
Subjects and methods

Subjects
The study protocol was advertised using posters and emails distributed within the University. Sixty subjects who expressed interest in participation were screened, and subsequently, 34 subjects who met the eligibility criteria were recruited and provided written informed consent before participating in the study. Inclusion criteria were age 20-55 years, non-obese (body mass index (BMI) o30 kg/m 2 ), nonsmokers, non-vegetarians, normal blood lipid profile, not consuming a special diet, no aversion to dairy products and not taking drugs that interfere with metabolism or food intake. Height was measured using a stadiometer on day 1 of the intervention. Body weight, fat mass and fat-free mass were estimated using bioelectrical impedance (Tanita body composition analyser, Model TBF-410) and waist circumference of each subject were measured in the morning of each study day. This study was approved by the Research Ethical Committee of the University of Ulster.
Study design
The study was of a randomised, double-blind, placebocontrolled, within-subject crossover design, conducted over a 3-month period. Each subject was studied for a period of 9 weeks in total (2 Â 3 weeks intervention phases, separated by a 3-week 'wash-out' phase). Hence, subjects were studied on three occasions in each phase with a 6-week interval between crossover. This differs from the previous short-term studies (Burns et al., 2000 (Burns et al., , 2001 (Burns et al., , 2002 , which had a 1-week interval between crossover. Similar to the previous Olibrat studies, the Olibrat fat emulsion was incorporated into yoghurt. Subjects were randomly assigned into two groups: group one received the test yoghurt in the first phase of the study and group two received the test yoghurt in the second phase of the study. The subject sequence was generated by simple randomisation, using random number sequence generated in SPSS. Each subject was asked to refrain from eating after 2100 hours on the evening before the first day of the study. At 0830 hours, subjects attended the metabolic suite at the University of Ulster where they consumed a 200 g portion of either the test or control yoghurt. All yoghurts were presented in plain white unmarked containers. After consuming the yoghurt, subjects resumed their normal morning activities, but were instructed not to eat or drink anything until lunchtime other than uncarbonated water if required. At 1300 hours, an ad libitium lunch was served in a private dining area within the University. All foods were covertly weighed before the meal and all uneaten foods were weighed after subjects had left the dining room. After lunch, subjects were permitted to eat and drink as they wished, but were asked to keep a weighed food record of all foods and beverages consumed during the remainder of the study day and the following day. The above protocol was followed on days 1 and 2, days 8 and 9 and days 22 and 23 of each study phase. In addition, fasting blood samples were drawn before yoghurt consumption on day 1 and day 22 of each phase. The subjects were free living, and during the intervening study days (days 2-7 and days 9-21), subjects consumed their habitual diet, but were asked to consume the 200 g portion of either the test or control yoghurt for breakfast. Subjects were free to eat other foods at breakfast and to follow their usual dietary patterns and activities. At the end of each phase, subjects completed a brief questionnaire, designed specifically for this study, to determine if there were any changes in self-perceived portion sizes of food eaten and in meal/lunch times during the study relative to usual. Lunch meal. Lunch was presented in a buffet style meal, offering a wide range of sweet and savoury foods. Each subject had their own separate serving area. Foods varied in macronutrient composition (Appendix A). All foods were served in larger than estimated average portion sizes, so that choice was not influenced by quantity. Foods were also served in separate serving dishes so as not to influence food choice combinations. Subjects had a choice of beverages including uncarbonated water, carbonated soft drinks including low-calorie options and diluted fruit juices. Tea and coffee were also available on request. Ad libitium consumption was permitted, and unlimited eating time was given to each subject.
Assessment of appetite
Subjects rated their perceived hunger, fullness, desire to eat, amount they could eat and preoccupation with thoughts of food on visual analogue scales (VAS; in mm), by pen and paper method. For example, hunger was rated on a 100 mm line preceded by the question 'How hungry do you feel?' and anchored on the left by 'not at all hungry' and on the right by 'as hungry as I have ever felt'. The anchors for the questions on perceived fullness, desire to eat, amount you could eat and preoccupation with thoughts of food consisted of the phrases 'not at all full' against 'as full as I have ever felt', 'very weak' against 'very strong', 'nothing at all' against 'a large amount' and 'no thoughts of food' against 'very preoccupied'. Subjects were instructed to make a single vertical mark at the appropriate point between the two anchors on each scale to indicate subjective feelings of hunger, perceived fullness, desire to eat, amount they could eat and preoccupation with thoughts of food, respectively, at defined time points (immediately before and 15 min after yoghurt consumption, and thereafter at hourly intervals until 2200 hours on all test days). Similarly, yoghurts were also rated for pleasantness of taste 15 min post-consumption of the test and control yoghurts on each study day on a 100 mm line preceded by the question 'How pleasant did you find the yoghurt' and anchored on the left by 'not at all pleasant' and on the right by 'very pleasant'.
Blood samples
In order to investigate if consumption of the Olibrat fat emulsion had an effect on blood profile in the medium-term, fasting blood samples were drawn on the first and last day of each study phase (days 1 and 22, respectively). Samples were analysed for total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides and glucose at the Causeway Laboratories, Causeway Hospital, Coleraine, UK. Additionally, plasma drawn at the beginning and end of each phase was stored at À701C and insulin concentrations were then measured upon completion of the study at the Regional Endocrine Laboratory, Royal Victoria Hospital, Belfast, UK.
Questionnaires
On day 1 of the intervention, subjects completed the Dutch Eating Behaviour Questionnaire (DEBQ) (van Strien et al., 1986) , the Binge Eating Scale (Gormally et al., 1982) , and the Rosenberg Self-Esteem Scale (Rosenberg, 1965) . The DEBQ measures dietary restraint using a 10-item scale, dietary emotional behaviour using a 13-item scale and dietary external behaviour using a 10-item scale. Scores are obtained by summing each scale and dividing by the number of items in each scale. Higher scores indicate higher restraint and greater vulnerability to emotional and external eating behaviour. The binge-eating scale assesses the severity of binge eating using a 16-item scale, with assigned scoring weights for each item (Gormally et al., 1982) . The Rosenberg Self-Esteem Questionnaire measures self-esteem using a 10-item scale. Higher scores indicated higher self-esteem, with 30 being the highest possible score.
Statistical analyses
Energy (MJ), macronutrient intakes (g) and weight of food consumed (g) at the ad libitum lunch and the subsequent self-reported intakes were calculated using Wisp V3 (Tinuviel Software, Warrington, UK). Food intake, VAS ratings, changes in anthropometric measurements and changes in blood profile were analysed using a general linear mixed effects model. Subjects were treated as random and the fixed effects were treatment, treatment phase and 'carry-over'. The treatment effect refers to differences in average food intakes, appetite ratings, changes in anthropometric measurements and changes in blood parameters between the test and control treatments. The treatment phase effect refers to differences in the average food intake, appetite ratings, changes in anthropometric measurements and changes in blood parameters between the first phase and the second phase of the study. The 'carry-over' term represents three possible effects that cannot be separated. These are: differences in carry-over from test to control, and vice versa, treatment-by-treatment phase interaction and differences between the two groups of subjects. Ideally, differences in 'carry-over' should not be present, as they contaminate the data from the second phase. Independent-samples t-tests were used to determine differences in anthropometric measurements, food intake and questionnaire outcomes between males and females, and differences in food intake between restrained and non-restrained eaters. All analysis were preformed using SPSS V11 (Statistical Package for Social Sciences, Version 11); results were considered significant at the Po0.05 level.
Results
Subject characteristics
The progress of subjects through the study is presented in Figure 1 . Four subjects withdrew from the study: two owing to personal circumstances, one failed to attend the first day of the study and one owing to illness unrelated to the study. These withdrawals occurred at early stages during the first phase. A further two subjects were omitted from the analyses owing to non-compliance with the completion of the weighed food diaries. Subsequently, 28 subjects (n ¼ 14 male; 14 female) were included in the final analysis. In addition, one subject was unable to attend the test lunch on day 8 of the second phase, and one subject was unable to provide a blood sample on day 22 of the second phase. Males had significantly greater heights, body weight, waist circumference and lean mass (Po0.001), but lower percentage body fat and fat mass (Po0.02) than females (Table 1) . There were no significant differences in age or BMI between males and females. The age range of the study population was 20-53 years and BMI ranged from 20.5 to 26.2 kg/m 2 . Based on the median split (2.6), 14 subjects were classified as restrained eaters (four males, 10 females) and 14 subjects were classified as non-restrained eaters (10 males, four females), as assessed by the DEBQ (Table 5) .
Energy and macronutrient intakes
There were no differences in mean energy, macronutrients or amounts of food consumed 4 h post-consumption of the test yoghurt compared to the control yoghurt on day 1, day 8 or day 22 in the total group, or in the gender-specific analyses (Table 2) . Energy intakes at the test lunches were consistently 34 suitable subjects enrolled onto the study 17 subjects assigned to group 1 (test treatment in phase 1) 60 subjects screened for eligibility 17 subjects assigned to group 2 (test treatment in phase 2) 2 subjects withdrew 1-personal reasons 1-illness unrelated to the study 2 subjects withdrew 1-personal reasons 1-failed to show up on day 1 of the study 1 subject omitted due to non-compliance Test lunch + VAS day 1 n = 10 day 8 n = 9 day 22 n = 10 1 subject omitted due to non-compliance
Final analysis
Test lunch + VAS: day 1 n = 28, day 8 n = 27, day 22 n = 28 Self-reported food intakes day 1 n = 28, day 8 n = 28, day 22 n = 28
Blood analysis n = 27 Anthropometric analysis n = 28 Self-reported food intake day 1 n = 10 day 8 n = 10 day 22 n = 10
Blood sample day 1 n = 10 day 22 n = 10
Test lunch + VAS day 1 n = 10 day 8 n = 10 day 22 n = 10
Self-reported food intake day 1 n = 10 day 8 n = 10 day 22 n = 10
Blood sample day 1 n = 10 day 22 n = 9
Figure 1 Flow of subjects through the study. Abbreviation: VAS, visual analogue scales. Mean7s.d. Differences between genders were determined using independent-samples t-tests.
higher in the male subjects compared to female subjects during both the control and test treatments (Po0.05). Additionally, there was no consistent effect of the test treatment on mean energy, macronutrients or weight of food eaten during the remainder of each study day and the post-study days (Table 3 ). In the total group, fat intake was significantly higher following consumption of the test yoghurt compared to control conditions on days 8 and 9 (post-study day) (132.5758.7 vs 105.1760.6 g, P ¼ 0.008). In male subjects, protein intake was significantly higher on days 1 and 2 (post-study day) (165.6753.6 vs 143.0754.7 g, P ¼ 0.048), whereas female subjects demonstrated significantly lower carbohydrate intake on days 1 and 2 (post-study day) (291.8767.6 vs 346.37103.2 g, P ¼ 0.035), and significantly lower weight of food eaten on days 22 and 23 (poststudy day) (34167945 vs 402471190 g, P ¼ 0.014) following consumption of the test yoghurt. Self-reported energy intakes were significantly higher in male subjects compared to female subjects during both the control and test treatments (Po0.05). According to the questionnaire completed by each subject at the end of each phase, there were no differences in self-reported dietary habits during the test or control treatments compared to habitual dietary behaviours.
Furthermore, when subjects were analysed according to their degree of restrained eating, no treatment effect was observed on mean energy, macronutrients or amounts of food consumed in either group 4 h post-consumption of the test yoghurt relative to control conditions on day 1, day 8 or day 22. During the remainder of the study day 22 and day 23 (post-study day), the weight of food consumed was significantly lower in the restrained eaters following consumption of the test yoghurt (3510.07984.1 vs 4451.471232.7 g, P ¼ 0.003). This reduction remained significant following adjustment for alcohol intake (3486.17967.7 vs 4403.671197.5 g, P ¼ 0.003). However, no reduction in weight of food eaten was observed on days 1 or 8 and the respective post-study days. Restrained eaters also had a significantly higher self-reported fat intake following consumption of the test yoghurt on days 8 and 9 (post-study day) (101.1724.4 vs 78.5738.4 g, P ¼ 0.030). Non-restrained eaters had a lower self-reported protein intake following consumption of the test yoghurt on days 1 and 2 (post-study day) (165.1750.3 vs 139.5754.8 g, P ¼ 0.025). Energy intakes at the test lunches were significantly lower in the restrained eaters compared to the non-restrained on days 1 and 8 of the test conditions and days 1, 8 and 22 of the control condition (Po0.05), but on day 22 of the test conditions, the difference was not significant. Additionally, self-reported energy intakes were also significantly lower in the restrained eaters compared to the non-restrained eaters for the remainder of study days 1, 8 and 22 and the respective post-study days of the test conditions, and days 1 and 8 and the respective post-study days of the control conditions (Po0.05), but on day 22 and 23 (post-study day) of the control conditions, the difference was not significant.
Individual differences in response to the test yoghurt containing the Olibrat emulsion
The individual difference in energy intakes for each subject 4 h post-consumption of the yoghurts on days 1, 8 and 22 are presented in Figures 2-4 . Thirteen subjects (46%; seven men and six women) had a lower energy intake at the test lunch following the consumption of the test yoghurt compared to the control yoghurt on day 1 (energy reduction ranged from À4 to À52%). Sixteen subjects (59%; eight men and eight women) had a lower energy intake at the test lunch on day 8 (energy reduction ranged from À4 to À39%), and 16 subjects (57%; eight men and eight women) had a lower energy intake at the test lunch on day 22 (energy reduction ranged from À3 to À49%). Seven subjects had consistently lower energy intakes at the three test lunches following consumption of the test yoghurts compared to the control yoghurt (energy reduction ranged from À4 to À52%), whereas only three subjects consistently increased their energy intakes following consumption of the test yoghurts compared to the control yoghurt (energy increase ranged from þ 4 to þ 89%).
Appetite ratings
There was no consistent treatment effect on ratings of perceived hunger, fullness, desire to eat, prospective consumption or preoccupation with thoughts of food on any of the test days in the group as a whole, or in gender-specific analyses. Perceived pleasantness for the test yoghurt and the 
Questionnaires
Results from the eating behaviour questionnaires are presented in Table 5 . Female subjects had significantly higher dietary restraint (2.170.7 vs 2.970.7, P ¼ 0.01) and dietary emotional behaviour (2.370.9 vs 3.370.8, P ¼ 0.004) scores compared to the male subjects.
Discussion
This study failed to confirm the short-term reduction in energy intake (over 4 h) following consumption of the Olibrat emulsion which was reported in earlier studies (Burns et al., 2000 (Burns et al., , 2001 (Burns et al., , 2002 . Furthermore, the Olibrat emulsion, did not appear to exert any suppressive effects on either mean food intake or appetite ratings in the mediumterm (up to 3 weeks). The emulsion exerted no effect on food intakes 4 h post-consumption. Although significant treatment effects were observed on the self-reported food intakes for the remainder of the study days and post-study days, these findings were inconsistent, and thus are difficult to interpret. Perhaps, the most interesting observation is the significant reduction in carbohydrate intake and the trend towards a lower energy intake after the test yoghurt on day 1 in the female subjects. In contrast, such reductions were not evident in the male subjects. Perhaps, the higher energy intake observed in the male subjects compared to the female subjects indicates that females may be more responsive/ sensitive to either, or both, the satiating potential of the emulsion or biological satiating signals.
The outcomes of three previous Olibrat studies have already been published (Burns et al., 2000 (Burns et al., , 2001 (Burns et al., , 2002 . All studies used yoghurt as the food vehicle for the emulsion, and all test meals were buffet-style, self-selected meals. In the first study, a sample of non-obese subjects consumed a Medium-term effects of Olibrat on food intake CM Logan et al defined breakfast, fasted until lunch when they received the yoghurt. Food intake was then covertly assessed 4 h postconsumption at an ad libitum meal and subjects recorded food intake for the remainder of the day using weighed dietary records. A subsequent study investigated the effect of the emulsion on food intake in groups of non-overweight, overweight and obese subjects. In this study, the yoghurt was consumed at breakfast, and food intake was covertly assessed 4 h post-consumption at an ad libitum lunch and again 4 h later at an ad libitum dinner. Weighed food diaries were completed for the remainder of the study day and the poststudy day. The final study evaluated the effects of various doses of Olibrat. Subjects received, for breakfast, a 200 g portion of yoghurt containing 15 g of fat with 0 g (control), 2, 4 or 6 g of the Olibrat fat, corresponding to 0, 5, 10 and 15 g of Olibrat emulsion, respectively. Food intake was covertly assessed 4 h post-consumption at an ad libitum meal, and again self-reported weighed food diaries were used to assess food intake for the remainder of the study day and the post-study day. However, owing to the difference in study designs, direct comparisons between the present study and previous studies can only be tentative.
It is also noteworthy that there was greater individual variation in response to the emulsion observed in this study compared to the previous studies. Data combined from the two previous studies, which tested the effect of a 12.5 g dose of Olibrat emulsion, revealed that approximately 75% of the subjects who participated in these studies (n ¼ 87) reduced their energy intake 4 h post-consumption of the test yoghurt relative to control conditions (Burns et al., 2000 (Burns et al., , 2001 . In the present study, 46% of subjects (n ¼ 13) reduced their intakes at 4 h post-consumption on day 1, 59% (n ¼ 16) on day 8 and 57% (n ¼ 16) on day 22, respectively. However, only seven subjects in the present study consistently reduced their energy intakes at all three of the test lunches. Thus, it appears that in addition to human appetite, other factors may exert powerful effects on food intake and eating behaviour. It is highly probable that these factors will simply over-ride normal appetite regulation in certain individuals. Hence, inter-individual differences in traits, such as restrained eating, may partially explain the differential responses in food intake between subjects in the present study. Given that the difference in eating behaviour between restrained eaters and non-restrained eaters is very evident throughout this study, this lends supports for the above hypothesis.
Ideally, a functional food that aims to increase satiety should result in weight loss. In this study, the Olibrat emulsion exerted no significant effects on any of the anthropometric indices measured. However, this is not a surprising result given that there was no reduction in food intake in response to the Olibrat emulsion during the study. In order to determine the potential impact of the emulsion on body weight, a longer-term study would clearly be necessary. Additionally, a functional food should not exert any adverse health effects. In the present study, there was a reduction in blood glucose during the test treatment compared to the control conditions in the male subjects. This may suggest an association between Olibrat consumption and altered glucose metabolism. However, further studies would be required to investigate this possible relationship and also to establish if indeed the effect is confined to male subjects only.
A number of factors can be proposed to explain the results of the present study. Firstly, in comparison to the earlier Olibrat studies, the eating environment in the present study was more sociable, in that 10 to 12 subjects were present at each lunch occasion. It has been reported that ambience, including social and physical surroundings, can influence eating behaviour and food intake (de Castro and de Castro, 1989; Stroebele and De Castro, 2004; Weber et al., 2004) . In fact, it has been suggested that the magnitude of the effect of ambience may be underestimated (Stroebele and De Castro, 2004) . It is possible that social facilitation attenuated by the relaxed atmosphere may have over-ridden normal appetite. Additionally, the initial Olibrat studies were conducted approximately 7 years ago. Considerable changes in dietary behaviour and patterns have been observed during this period of time, including increased portion sizes (Nielsen and Popkin, 2003) , greater tendency to eat away from the home and a greater reliance on convenience foods (Harnack et al., 2000) . Therefore, it could be speculated that these changes in dietary behaviour may have collectively resulted in a greater susceptibility to environmentally driven cues to overeat under the present study conditions.
There are a number of other issues, common to all food intake studies, which may have also influenced the study outcomes. Firstly, mis-reporting of food intakes by the subjects may have confounded results (Livingstone et al., 1990) . Although it could be argued that this may be the case in the previous studies, mis-reporting appears to be a problem that has intensified since it was first identified as a problem in studies assessing food intake (Heitmann et al., 2000) . Thus, self-reported intakes may not have been the most appropriate method to assess food intakes in a study aimed specifically at reducing food intake, as this method may not be sensitive enough to detect any change in energy intakes induced by the emulsion. Therefore, it is likely that a study conducted within a residential setting, in which all food consumed can be assessed by covert weighing would be a more suitable approach. Secondly, eating behaviour is likely to be influenced by a free lunch in which a wide range of foods served in extra large portion sizes are presented (Rolls, 1985; Rolls et al., 2002; Sorensen et al., 2003) . This may have assumed greater relevance of late, given that the prevalence of obesity continues to increase (Flegal et al., 2002; McCarthy et al., 2002) , and many people have become preoccupied, even obsessed with food, eating and body image. Thirdly, the statistical power of the study may have been inadequate. Initially, 34 subjects were involved in the study; however, only 28 were included in the final analyses. Perhaps, a larger sample size may have yielded more obvious trends and significant results. Finally, unquantifiable factors present in one phase of the study may not have been present in the other study phase. For example, this study was conducted between August and November, consequently seasonal effect may have influenced food intake (Shahar et al., 2001) . Although several issues have been highlighted that may partially explain these results, it may be that the Olibrat emulsion simply did not exert any effect on food intake at mean level in this cohort of subjects. In conclusion, the Olibrat emulsion did not exert any short-or medium-term effects on food intake or appetite ratings in this study. At present, it is not possible to state if this lack of effect is real or apparent owing to a variable combination of factors discussed above. Hence, further studies, taking into account potential confounding factors and varying the dose of Olibrat given, are necessary to establish the effects of the Olibrat emulsion in the medium term. Furthermore, if, as the study suggests, that environmental cues are becoming the major driving force behind food intake, and people are becoming less responsive and less aware of physiological appetite signals, the development of a functional food aimed at reducing food intake will prove increasingly difficult. Indicates foods that were served in the centre of the dining tables. b Indicates foods that were reused throughout the study, replaced when quantity may have influenced choice of food; values reported are unopened weight of food.
